Suppr超能文献

基于肿瘤体积倍增时间的肝癌术后患者随访检查时间表

Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.

作者信息

Okada S, Okazaki N, Nose H, Aoki K, Kawano N, Yamamoto J, Shimada K, Takayama T, Kosuge T, Yamasaki S

机构信息

Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Hepatogastroenterology. 1993 Aug;40(4):311-5.

PMID:7691698
Abstract

The tumor volume doubling time of 27 recurrent hepatocellular carcinoma nodules measuring < or = 2.0 cm in diameter discovered after hepatectomy in 19 patients was analyzed by ultrasonography for 31 to 331 days. The tumor volume doubling time ranged from 39 to 420 days before specific treatment, with a mean of 112 days and a median of 80 days. It correlated with age and intrahepatic site of recurrence, which was sometimes the same lobe as that of the prior hepatocellular carcinoma, sometimes not. The tumor volume doubling time also tended to correlate with hepatitis C antibody status and initial tumor diameter. The tumor volume doubling time was, however, independent of sex, hepatitis B surface antigen status, number of recurrent tumors, initial serum alpha-fetoprotein level, interval between hepatectomy and recurrence detection, and associated liver disease. On the basis of the shortest tumor volume doubling time of the recurrent hepatocellular carcinoma nodules, we recommend that US and/or CT be performed at least every four months to screen for small recurrent carcinomas in postoperative patients.

摘要

对19例肝切除术后发现的27个直径≤2.0 cm的复发性肝细胞癌结节进行超声检查分析,其肿瘤体积倍增时间为31至331天。在进行特异性治疗前,肿瘤体积倍增时间为39至420天,平均为112天,中位数为80天。它与年龄和肝内复发部位相关,复发部位有时与先前肝细胞癌在同一肝叶,有时则不同。肿瘤体积倍增时间也倾向于与丙型肝炎抗体状态和初始肿瘤直径相关。然而,肿瘤体积倍增时间与性别、乙型肝炎表面抗原状态、复发性肿瘤数量、初始血清甲胎蛋白水平、肝切除与复发检测之间的间隔时间以及相关肝病无关。基于复发性肝细胞癌结节最短的肿瘤体积倍增时间,我们建议术后患者至少每四个月进行一次超声和/或CT检查,以筛查小的复发性癌。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验